PKP1 and adenocarcinoma: By incorporating PKP1 into algorithm-driven panels that integrate IHC, genomic, and morphologic features (e.g., alongside PD-L1 for immune context, TTF-1/Napsin A for adenocarcinoma, and p63 for SCC), its contribution can be dynamically weighted to enhance diagnostic accuracy.